| __timestamp | Galapagos NV | Jazz Pharmaceuticals plc |
|---|---|---|
| Wednesday, January 1, 2014 | 111110000 | 85181000 |
| Thursday, January 1, 2015 | 129714000 | 135253000 |
| Friday, January 1, 2016 | 139574000 | 162297000 |
| Sunday, January 1, 2017 | 218502000 | 198442000 |
| Monday, January 1, 2018 | 322876000 | 226616000 |
| Tuesday, January 1, 2019 | 427320000 | 299726000 |
| Wednesday, January 1, 2020 | 523667000 | 335375000 |
| Friday, January 1, 2021 | 491707000 | 505748000 |
| Saturday, January 1, 2022 | 515083000 | 590453000 |
| Sunday, January 1, 2023 | 241294000 | 849658000 |
Igniting the spark of knowledge
In the competitive landscape of biopharmaceuticals, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Jazz Pharmaceuticals plc and Galapagos NV have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Galapagos NV's R&D expenses surged by approximately 117%, peaking in 2020. However, a notable decline occurred in 2023, with expenses dropping by over 50% from the previous year. In contrast, Jazz Pharmaceuticals exhibited a steady increase, culminating in a remarkable 850% rise in 2023 compared to 2014.
This divergence highlights the dynamic nature of the biopharma sector, where strategic shifts and market conditions can significantly impact R&D priorities. As these companies navigate the future, their R&D strategies will be pivotal in shaping their competitive edge and innovation potential.
Who Prioritizes Innovation? R&D Spending Compared for Alnylam Pharmaceuticals, Inc. and Galapagos NV
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Alpine Immune Sciences, Inc.
R&D Insights: How Jazz Pharmaceuticals plc and Ultragenyx Pharmaceutical Inc. Allocate Funds
Research and Development Investment: Jazz Pharmaceuticals plc vs Pharming Group N.V.
Comparing Innovation Spending: Jazz Pharmaceuticals plc and MorphoSys AG
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Alpine Immune Sciences, Inc. and Galapagos NV
Analyzing R&D Budgets: Verona Pharma plc vs Galapagos NV
Analyzing R&D Budgets: Amneal Pharmaceuticals, Inc. vs Galapagos NV
Comparing Innovation Spending: Apellis Pharmaceuticals, Inc. and Galapagos NV
CRISPR Therapeutics AG vs Galapagos NV: Strategic Focus on R&D Spending